Al-Hadithy, D.A.; Al-Maqbali, J.S.; Al-Riyami, A.; Al Za’abi, M.; Al-Zakwani, I.
The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman. Pharmacy 2023, 11, 79.
https://doi.org/10.3390/pharmacy11030079
AMA Style
Al-Hadithy DA, Al-Maqbali JS, Al-Riyami A, Al Za’abi M, Al-Zakwani I.
The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman. Pharmacy. 2023; 11(3):79.
https://doi.org/10.3390/pharmacy11030079
Chicago/Turabian Style
Al-Hadithy, Dalia Ahmed, Juhaina Salim Al-Maqbali, Adil Al-Riyami, Mohammed Al Za’abi, and Ibrahim Al-Zakwani.
2023. "The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman" Pharmacy 11, no. 3: 79.
https://doi.org/10.3390/pharmacy11030079
APA Style
Al-Hadithy, D. A., Al-Maqbali, J. S., Al-Riyami, A., Al Za’abi, M., & Al-Zakwani, I.
(2023). The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman. Pharmacy, 11(3), 79.
https://doi.org/10.3390/pharmacy11030079